Balaji Amines Limited (BOM:530999)

Market Cap	39.23B
Revenue (ttm)	13.64B
Net Income (ttm)	1.46B
Shares Out	32.40M
EPS (ttm)	45.00
PE Ratio	26.91
Forward PE	19.26
Dividend	11.00 (0.91%)
Ex-Dividend Date	Aug 1, 2025

Volume	76,839
Average Volume	144,254
Open	1,212.00
Previous Close	1,209.90
Day's Range	1,201.00 - 1,265.85
52-Week Range	1,066.05 - 1,946.00
Beta	0.49
RSI	54.41
Earnings Date	Jan 29, 2026

About Balaji Amines

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene...

• Industry: Industrial Organic Chemicals
• Founded: 1988
• Employees: 1,169
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 530999

Financial Performance

In 2024, Balaji Amines's revenue was 13.97 billion, a decrease of -14.89% compared to the previous year's 16.42 billion. Earnings were 1.58 billion, a decrease of -23.11%.